Statement on the Global Fund’s landmark agreement to procure long-acting HIV prevention injectable for low- and middle-income countries Chris Collins,...
Written Testimony submitted by Chris Collins, President and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria,...
Statement on FDA approval of lenacapavir from Chris Collins, President and CEO, Friends of the Global Fight “The twice-yearly HIV...
The enduring impact of the 1:2 match requirement on U.S. support of the Global Fund Click here to download a PDF...
Innovation to end the HIV, TB and malaria epidemics: Global Fund accelerating progress, focused on communities Click here to download...
Providing a $2 billion appropriation for the Global Fund in fiscal year 2026 would support lifesaving interventions, enhance U.S. health...
Find out how U.S investment in the Global Fund partnership yields strong returns—saving millions of lives, spurring critical innovations and inspiring other donors.
On November 13th, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria and the Georgetown University Global Health Institute...
“I will not allow anyone else to die”: Treating Pediatric HIV in Malawi Phoebe Nyasulu watched several of her siblings...
Leveraging Tuberculosis Programs for Future Pandemic Preparedness: A Retrospective Look on COVID-19 A new report in PLOS, “Leveraging Tuberculosis Programs...
How Business Can Catalyze Civil Society Participation in Healthcare Policy and Delivery By Mark P. Lagon and Bennett Freeman Over...
On July 10th, Friends of the Global Fight hosted an awards reception to honor the remarkable impact of bipartisan congressional leadership on the Global Fund and global health. The event recognized Senator John Boozman, Representative Pete Aguilar, Representative Mario Diaz-Balart, Representative Grace Meng and faith leader Shepherd Smith for their dedication to fighting HIV/AIDS, tuberculosis and malaria.
